SCHEMBL13409498

SCHEMBL13409498

CSc1cnc(-n2ccc3cc(N(CC(=O)O)S(=O)(=O)C4C=C(Cl)C=C(Cl)C4)ccc32)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13409158 0.91 DGAT1 (0.32)
SCHEMBL13409506 0.89 SMN1; SMN2 (0.32)
SCHEMBL13409237 0.89
SCHEMBL13409234 0.87
SCHEMBL13409242 0.86 RORC (0.36)
SCHEMBL13409331 0.86 SMN1; SMN2 (0.32)
SCHEMBL13409270 0.86 HSP90AA1 (0.33)
SCHEMBL13409633 0.85 PAICS (0.31)
SCHEMBL13409271 0.85
SCHEMBL13409644 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093703-A1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-15 US disclosed